All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-CQ2135 | Anti-SEMA3E (CBXS-1816) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXS-1816 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ2136 | Anti-SEMA3E (CBXS-0200) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXS-0200 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ2137 | Anti-SEMA3E (CBXS-1817) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXS-1817 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ2138 | Anti-SEMA3E (CBXS-2417) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXS-2417 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ2139 | Anti-SEMA3E (CBXS-3403) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXS-3403 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5559 | Anti-SEMA3E (CBXS-1816) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXS-1816 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5560 | Anti-SEMA3E (CBXS-0200) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXS-0200 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5561 | Anti-SEMA3E (CBXS-1817) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXS-1817 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5562 | Anti-SEMA3E (CBXS-2417) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXS-2417 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5563 | Anti-SEMA3E (CBXS-3403) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXS-3403 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
XS-1222-ZP1137 | SEMA3E (PLXND1 Receptor) h(CD28-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | SEMA3E-CD28-CD6ζ | Lentiviral vector | T cell | ||||
XS-1222-ZP2537 | SEMA3E (PLXND1 Receptor) h(41BB-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | SEMA3E-41BB-CD6ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION